Our clinical obeservation indicated that the patient B showed low level of cytokines such as IL-6, MCP-3, MCP-1, IP-10 and IL-1α after treatment with LS, which hinted that LS could prevent COVID-19 into hyperinflammatory status. The gene discussed is IL1A; the disease is COVID-19.